193
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Distinguishing Patients with Stage I Lung Cancer Versus Control Individuals using Serum Mass Profiling

, , , , , , , , , , & show all
Pages 136-143 | Received 23 Aug 2013, Accepted 11 Jan 2014, Published online: 28 Feb 2014

REFERENCES

  • American Cancer Society. Cancer Facts & Figures. Atlanta (GA): American Cancer Society, Inc., 2012. Available at: http://www. cancer.org/docroot/STT/content/STT_1x_Cancer_Facts_Figures_ 2012.asp?from=fast
  • National Lung Screening Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395–409.
  • Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med 2003;348:2535–2542.
  • Alzahouri K, Velten M, Arveux P, Woronoff-Lemsi MC, Jolly D, Guillemin F. Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: a multicentre study in 18 French districts. BMC Cancer 2008;8:93.
  • Swensen SJ, Jett JR, Hartman TE, Midthun DE, Sloan JA, Sykes AM, Aughenbaugh GL, Clemens MA. Screening for lung cancer with CT: mayo clinic experience. Radiol 2003;226:756–761.
  • Midthun DE, Swensen SJ, Jett JR, Hartman TE. Evaluation of nodules detected by screening for lung cancer with low dose spiral computed tomography. Lung Cancer 2003;41(Suppl. 2):S40.
  • MacMahon H, Austin JHM, Gamsu G, Herold CJ, Jett JR, Naidich DP, Patz EF, Jr, Swensen SJ. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner society. Radiol 2005;237:395–400.
  • Gelbman BD, Cham MD, Kim W, Libby DM, Smith JP, Port JL, Altorki NK, Henschke CI, Yankelevitz DF. Radiographic and clinical characterization of false negative results from CT-guided needle biopsies of lung nodules. J Thorac Oncol 2012;7:815–820.
  • Kemp RA, Reinders DM, Turic B. Detection of lung cancer by automated sputum cytometry. J Thoracic Oncol 2007;2:993–1000.
  • Oshita F, Ito H, Ikehara M, Ohgane N, Hamanaka N, Nakayama H, Saito H, Yamada K, Noda K, Mitsuda A, Kameda Y. Prognostic impact of survivin, cyclin D1, integrin 1, and VEGF in patients with small adenocarcinoma of stage I lung cancer. Amer J Clin Oncol 2004;27:425–428.
  • Luo XY. Chen HQ, Sun YH, Zhou JH, Wang WF, Liao P. Xian. Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules. Chinese J Oncol 2006;28:907–910.
  • Shen J, Liu Z, Todd NW, Zhang H, Liao J, Yu L, Guarnera MA, Li R, Cai L, Zhan M, Jiang F. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 2011;11:374.
  • Richter R, Schuz-Knappe P, Schrader M, Standker L, Jurgens M, Tammen H, Forssmann WG. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. J Chrom B Biomed Sci Appl 1999;726:25–35.
  • Chambers G, Lawrie L, Cash P, Murray GL. Proteomics: a new approach to the study of disease. J Pathol 2000;192:280–288.
  • Verma M, Wright GL Jr, Hanash SM, Gopal-Srivastava R, Srivastava S. Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. Annal NY Acad Sci 2001;945:103–115.
  • Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, Fleisher M, Lilja H, Brogi E, Boyd J, Sanchez-Carbayo M, Holland EC, Cordon-Cardo C, Scher HI, Tempst P. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006;116:271–284.
  • Bianchi ME. DAMPs, PAMPs, and alarmins: all we need to know about danger. J Leukocyte Biol 2007;81:1–5.
  • Hanas JS, Hocker JR, Cheung JY, Larabee JL, Lerner MR, Lightfoot SA, Morgan DL, Denson KD, Prejeant KC, Gusev, Y, Smith BJ, Hanas RJ, Postier RG, Brackett DJ. Biomarker identification in human pancreatic cancer sera. Pancreas 2008;36:61–69.
  • Hocker JR, Peyton MD, Lerner MR, Mitchell SL, Lightfoot SA, Lander TJ, Bates-Albers LM, Vu NT, Hanas RJ, Kupiec TC, Brackett DJ, Hanas JS. Serum profiling of stage I/II lung cancer patients using electrospray-ionization mass spectrometry. Lung Cancer 2011;74:206–211.
  • Hocker JR, Peyton MD, Lerner MR, Lightfoot SA, Hanas RJ, Brackett DJ, Hanas JS. Distinguishing non-small cell lung adenocarcinoma patients from squamous cell carcinoma patients and from control individuals using serum profiling. Cancer Invest 2012;30:180-188.
  • Hocker JR, Lerner MR, Mitchell SL, Lightfoot SA, Lander TJ, Quillet AA, Hanas RJ, Peyton MD, Postier RG, Brackett DJ, Hanas JS. Distinguishing early-stage pancreatic cancer patients from disease-free individuals using serum profiling. Cancer Invest 2011;29:173–179.
  • Hocker JR, Bishop EA, Lightfoot SA, Lerner MR, Peyton MD, Brackett DJ, Hanas RJ, McMeekin DS, Walker JL, Hanas JS. Serum profiling to distinguish early-stage and late-stage ovarian cancer patients from disease-free individuals. Cancer Invest 2012;30:189–197.
  • Greene FL, Sobin LH. A worldwide approach to the TNM staging system: collaborative efforts of the AJCC and UICC. J Surg Oncol 2009;99:269–272.
  • Tuck MK, Chan DW, Chia D, Godwin AK, Grizzle WE, Krueger KE, Rom W, Sanda M, Sorbara L, Stass S, Wang W, Brenner DE. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res 2009;8:113–117.
  • Ransohoff DF. Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev Cancer 2004;4:309–314.
  • Guan W, Zhou M, Hampton CY, Benigno BB, Walker LD, Gray A, McDonald JF, Fernandez FM. Ovarian cancer detection from metabolomic liquid chromatography/mass spectrometry data by support vector machines. BMC Bioinfo 2009;10:259–274.
  • Postier RG, Lerner MR, Lightfoot SA, Vannarath R, Lane MM, Hanas JS, Brackett DJ. DNA ploidy and markovian analysis of neoplastic progression in experimental pancreatic cancer. J Histochem Cytochem 2003;51:303–309.
  • Altman DG, Bland M. Statistics notes: diagnostic tests 2: predictive values. Brit Med J 1994;309:102.
  • Altman DG, Bland M. Statistics notes: diagnostic tests 1: sensitivity and specificity. Brit Med J 1994;308:1552.
  • Solitary pulmonary nodule, Wikipedia Free Access, 2008; Available at: http://en.wikipedia.org/wiki/File:Thorax_CT_peripheres_ Brronchialcarcinom_li_OF.jpg
  • Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, Cazares LH, Chan DW, Grizzle WE, Izbicka E, Kagan J, Malik G, McLerran D, Moul JW, Partin A, Prasanna P, Rosenzweig J, Sokoll LJ, Srivastava S, Srivastava S, Thompson I, Welsh MJ, White N, Winget M, Yasui Y, Zhang Z, Zhu L. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem 2005;51: 102–112.
  • Hortin GL. Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? Clin Chem 2005;51:3–5.
  • West-Nørager M, Bro R, Marini F, Høgdall EV, Høgdall CK, Nedergaard L, Heegaard NH. Feasibility of serodiagnosis of ovarian cancer by mass spectrometry. Anal Chem 2009;81:1907–1913.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.